SP600125 inhibits cap-dependent translation independently of the c-Jun N-terminal kinase pathway
Related Experiment Video
Updated: Jun 5, 2026

Xenopus laevis as a Model to Identify Translation Impairment
Published on: September 27, 2015
Masatoshi Ito1, Hiroshi Kitamura, Chisato Kikuguchi
1Laboratory for Immunogenomics, RIKEN Research Center for Allergy and Immunology, Yokohama 230-0045, Japan.
Abstract:
We investigated the effects of SP600125 (formerly called c-Jun N-terminal kinase (JNK) inhibitor II) on translation using cultured mouse cells. SP600125 (50 µM) treatment rapidly repressed overall protein synthesis, accompanied by a reduction in the mRNAs for housekeeping genes such as glyceraldehyde-3-phosphate dehydrogenase in the polysomal fraction. SP600125 decreased polysomes with a concomitant increase in free ribosomal subunits in the cytoplasm, suggesting that global translation was inhibited at the initiation step. A reporter analysis using exogenous mRNAs showed that SP600125 inhibited cap-dependent but not internal ribosome entry site-dependent translation. SP600125 significantly attenuated phosphorylation of components in the mTOR pathway, which is responsible for cap-dependent translation. In contrast to SP600125, short hairpin RNAs for JNK1 and JNK2 failed to affect overall protein synthesis. Collectively, SP600125 inhibits cap-dependent translation, independent of the JNK pathway.
Related Concept Videos
The JAK-STAT Signaling Pathway
Inhibitors of Viral Protein Synthesis
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Inhibition of Cdk Activity
Inhibition of CDK Activity
cAMP-dependent Protein Kinase Pathways

